Marfan disease
## **Core Concept**
Marfan disease, also known as Marfan syndrome, is a genetic disorder that affects the body's connective tissue. It is characterized by tall stature, long limbs, and a predisposition to cardiovascular, musculoskeletal, and ocular abnormalities. The underlying cause is a mutation in the **FBN1 gene**, which encodes fibrillin-1, a protein crucial for the formation of elastic fibers found in connective tissue.
## **Why the Correct Answer is Right**
The correct answer involves understanding the genetic basis and clinical manifestations of Marfan syndrome. The **FBN1 gene mutation** leads to the production of abnormal fibrillin-1, affecting the structural integrity of connective tissue. This results in the characteristic features of Marfan syndrome, including aortic root dilatation, ectopia lentis, and skeletal abnormalities. The involvement of the **FBN1 gene** is key to diagnosing and understanding the pathophysiology of Marfan syndrome.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not accurately represent the genetic basis of Marfan syndrome. While specific genes and mutations are associated with Marfan syndrome, option A is not specified, making it impossible to assess its accuracy directly.
- **Option B:** This option is incorrect as it also does not accurately represent the established genetic cause of Marfan syndrome. Without specific details, it's clear that B does not correspond with the known association of **FBN1 gene** mutations.
- **Option D:** This option is incorrect because it suggests an alternative that does not align with the established medical knowledge regarding Marfan syndrome's genetic cause.
## **Clinical Pearl / High-Yield Fact**
A crucial clinical pearl for Marfan syndrome is that patients are at a high risk of **aortic aneurysms and dissections** due to the involvement of the aortic root. Early diagnosis and monitoring, particularly of the cardiovascular system, are critical in managing Marfan syndrome. A classic clinical correlation is the use of **beta-blockers** as a first-line treatment to reduce the force of blood ejected from the heart, thereby reducing stress on the aortic wall.
## **Correct Answer:** C. FBN1 gene.